Skip To Main Content
Lilly
Menu closed
Lilly
  • Account Login / Register
  • Medical Home
    • Medical Information
  • Medical Education
  • Science
Ask Lilly

We're here to help.

Chat
Chat with us Chat with us
Question Contact Us
Expand contact lilly
Lilly

You are now leaving the LillyMedical.com website

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to LillyMedical.com.

  1. Medical Information Right
  2. Diabetes Right
  3. Humalog Therapies Right
  4. Is dose adjustment needed when transitioning from another insulin to Humalog® (insulin lispro) 100 units/mL?
Search Humalog (type in keywords)
Search Medical Information

If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)

Loading icon

Humalog® Therapies

Humalog® U-100 (insulin lispro injection)

100 units/mL
Full Prescribing Information

Humalog® U-200 (insulin lispro injection)

200 units/mL
Full Prescribing Information

Humalog® MIX50/50™ (50% insulin lispro protamine suspension 50% insulin lispro injection [rDNA origin])

100 units/mL
Full Prescribing Information

Humalog® MIX75/25™ (75% insulin lispro protamine suspension 25% insulin lispro injection [rDNA origin])

100 units/mL
Full Prescribing Information

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

Is dose adjustment needed when transitioning from another insulin to Humalog® (insulin lispro) 100 units/mL?

Dose adjustment may be needed when transitioning from another insulin to Humalog 100 units/mL.

US_cFAQ_LIS216_CHANGING_OTHER_MEALTIME_INSULIN
US_cFAQ_LIS216_CHANGING_OTHER_MEALTIME_INSULIN
en-US

Dose Adjustment

Dose adjustment may be needed when transitioning from another insulin to Humalog® (insulin lispro injection) 100 units/mL.1

The patient's glycemic control and predisposition to hypoglycemia or hyperglycemia may be affected by changes in insulin regimen such as

  • insulin strength
  • manufacturer
  • type
  • injection site, or
  • method of administration.1

Any changes to insulin regimen for a patient with diabetes mellitus should be made cautiously and under close medical supervision and the frequency of blood glucose monitoring should be increased.1

Enclosed Prescribing Information

HUMALOG® (insulin lispro injection), for subcutaneous or intravenous use, Lilly

Reference

1Humalog [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.

Date of Last Review: July 04, 2022

Are you satisfied with this content?

Can't find what you're looking for? Contact us for answers to your medical questions.

  • Copyright
  • Terms of Use
  • Privacy Statement
  • Accessibility Statement
  • Sitemap

    This site is intended for US Healthcare Professionals only.

    4.0.17 02/2023 | GLOOTH00001 04/2015 | © Lilly USA, LLC 2023. All rights reserved.

    Product names listed above are trademarks or registered trademarks owned by or licensed to Eli Lilly and Company, its subsidiaries, or affiliates

    facebook twitter linkedin
    visit www.phactmi.org
    Lilly